Literature DB >> 348030

E. coli meningitis: K1 antigen and virulence.

C M Wilfert.   

Abstract

It is clear from the preceding material that bacterial infection is a significant threat to the newborn infant. The most common gram-negative organism causing meningitis in the neonate is E. coli, and the invasive capacity of this organism is correlated with its polysaccharide antigen, K1. Careful studies of supportive care and antimicrobial therapy of these infections are continuing. If antibodies could be generated which protect the infant, it would be theoretically possible to guard against infasive disease by conferring antibody positivity to the mother and hence to the infant. Investigations along these lines are continuing.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348030     DOI: 10.1146/annurev.me.29.020178.001021

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  5 in total

1.  Analysis of the K1 capsule biosynthesis genes of Escherichia coli: definition of three functional regions for capsule production.

Authors:  G J Boulnois; I S Roberts; R Hodge; K R Hardy; K B Jann; K N Timmis
Journal:  Mol Gen Genet       Date:  1987-06

2.  YbdO Promotes the Pathogenicity of Escherichia coli K1 by Regulating Capsule Synthesis.

Authors:  Yu Fan; Hongmin Sun; Wen Yang; Jing Bai; Peng Liu; Min Huang; Xi Guo; Bin Yang; Lu Feng
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

3.  Rapid identification of Escherichia coli pathotypes by virulence gene detection with DNA microarrays.

Authors:  Sadjia Bekal; Roland Brousseau; Luke Masson; Gabrielle Prefontaine; John Fairbrother; Josée Harel
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Cloning and analysis of the K1 capsule biosynthesis genes of Escherichia coli: lack of homology with Neisseria meningitidis group B DNA sequences.

Authors:  C Echarti; B Hirschel; G J Boulnois; J M Varley; F Waldvogel; K N Timmis
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

5.  Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.

Authors:  J M Mylotte; T R Bates; K A Sergeant; R E Matson; T R Beam
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.